GB0615129D0 - Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies - Google Patents
Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapiesInfo
- Publication number
- GB0615129D0 GB0615129D0 GBGB0615129.4A GB0615129A GB0615129D0 GB 0615129 D0 GB0615129 D0 GB 0615129D0 GB 0615129 A GB0615129 A GB 0615129A GB 0615129 D0 GB0615129 D0 GB 0615129D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- bmp
- cancer
- activity
- therapies
- cancer therapies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0615129.4A GB0615129D0 (en) | 2006-07-29 | 2006-07-29 | Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies |
PCT/GB2007/002755 WO2008015383A2 (en) | 2006-07-29 | 2007-07-20 | Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0615129.4A GB0615129D0 (en) | 2006-07-29 | 2006-07-29 | Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0615129D0 true GB0615129D0 (en) | 2006-09-06 |
Family
ID=37006438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0615129.4A Ceased GB0615129D0 (en) | 2006-07-29 | 2006-07-29 | Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0615129D0 (en) |
WO (1) | WO2008015383A2 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2561048T3 (en) | 2004-07-23 | 2016-02-24 | Acceleron Pharma Inc. | ActRII receptor polypeptides |
US8128933B2 (en) | 2005-11-23 | 2012-03-06 | Acceleron Pharma, Inc. | Method of promoting bone growth by an anti-activin B antibody |
EA201692543A1 (en) | 2005-11-23 | 2017-08-31 | Акселерон Фарма Инк. | ACTIVIN-ACTRIIA ANTAGONISTS AND THEIR APPLICATION FOR STIMULATING BONE GROWTH |
US8895016B2 (en) | 2006-12-18 | 2014-11-25 | Acceleron Pharma, Inc. | Antagonists of activin-actriia and uses for increasing red blood cell levels |
MX354099B (en) | 2007-02-01 | 2018-02-13 | Acceleron Pharma Inc | Activin-actriia antagonists and uses for treating or preventing breast cancer. |
TW201627320A (en) | 2007-02-02 | 2016-08-01 | 艾瑟勒朗法瑪公司 | Variants derived from ActRIIB and uses therefor |
KR20180083967A (en) | 2007-02-09 | 2018-07-23 | 악셀레론 파마 인코포레이티드 | Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
CN101861161B (en) | 2007-09-18 | 2017-04-19 | 阿塞勒隆制药公司 | Activin-ACTRIIA antagonists and uses for decreasing or inhibiting FSH secretion |
WO2009084738A1 (en) * | 2007-12-28 | 2009-07-09 | Kyowa Hakko Kirin Co., Ltd. | Method and pharmaceutical composition for treatment of cancer using bmp9 protein |
WO2009084739A1 (en) * | 2007-12-28 | 2009-07-09 | Kyowa Hakko Kirin Co., Ltd. | Method and pharmaceutical composition for treatment of cancer using bmp10 protein, |
CA2733911C (en) | 2008-08-14 | 2019-09-03 | Acceleron Pharma Inc. | Use of gdf traps comprising variant actriib polypeptides to increase red blood cell levels |
US8216997B2 (en) | 2008-08-14 | 2012-07-10 | Acceleron Pharma, Inc. | Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators |
AU2010204985A1 (en) | 2009-01-13 | 2011-08-04 | Acceleron Pharma Inc. | Methods for increasing adiponectin |
KR20120049214A (en) | 2009-06-08 | 2012-05-16 | 악셀레론 파마 인코포레이티드 | Methods for increasing thermogenic adipocytes |
KR20190090049A (en) | 2009-06-12 | 2019-07-31 | 악셀레론 파마 인코포레이티드 | TRUNCATED ActRIIB-FC FUSION PROTEINS |
WO2011063018A1 (en) | 2009-11-17 | 2011-05-26 | Acceleron Pharma Inc. | Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy |
EP2638065A4 (en) | 2010-11-08 | 2014-04-09 | Acceleron Pharma Inc | Actriia binding agents and uses thereof |
US9809636B2 (en) | 2012-04-06 | 2017-11-07 | Acceleron Pharma Inc. | Methods for increasing red blood cell levels comprising administering BMP9 |
EP2914277B1 (en) | 2012-11-02 | 2017-09-13 | Celgene Corporation | Activin-actrii antagonists and uses for treating bone and other disorders |
MA40008A (en) | 2014-06-13 | 2021-05-05 | Acceleron Pharma Inc | ANTAGONIST ACTRII FOR THE TREATMENT AND PREVENTION OF SKIN ULCER IN A SUBJECT WITH ANEMIA |
MA41052A (en) | 2014-10-09 | 2017-08-15 | Celgene Corp | TREATMENT OF CARDIOVASCULAR DISEASE USING ACTRII LIGAND TRAPS |
HRP20230504T1 (en) | 2014-12-03 | 2023-09-15 | Celgene Corporation | Activin-actrii antagonists and uses for treating myelodysplastic syndrome |
CN109311956A (en) | 2015-08-25 | 2019-02-05 | 伊斯迪德股份公司 | Compound for inducing tissue formation and application thereof |
EP3349776B1 (en) * | 2015-09-17 | 2020-12-30 | Histide AG | Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof |
CA2998455A1 (en) * | 2015-09-17 | 2017-03-23 | Histide Ag | Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof |
WO2023069447A1 (en) * | 2021-10-18 | 2023-04-27 | The Uab Research Foundation | Bmp9 or an agonist thereof and its uses related to reducing metastasis of cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1435243A3 (en) * | 1998-11-13 | 2005-02-09 | Curis, Inc. | Methods of alleviating cancer symptoms |
US20060039949A1 (en) * | 2004-08-20 | 2006-02-23 | Nycz Jeffrey H | Acetabular cup with controlled release of an osteoinductive formulation |
EP1802326A2 (en) * | 2004-09-09 | 2007-07-04 | Stryker Corporation | Methods for treating bone tumors using bone morphogenic proteins |
-
2006
- 2006-07-29 GB GBGB0615129.4A patent/GB0615129D0/en not_active Ceased
-
2007
- 2007-07-20 WO PCT/GB2007/002755 patent/WO2008015383A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008015383A2 (en) | 2008-02-07 |
WO2008015383A8 (en) | 2009-07-16 |
WO2008015383A3 (en) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0615129D0 (en) | Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies | |
HK1136822A1 (en) | Therapeutic compounds and their use in cancer | |
GB2435217B (en) | Improvements in and relating to neurostimulation | |
IL192281A0 (en) | Morpholino pyrimidine derivatives and their use in therapy | |
LT2999791T (en) | Capsid-modified, raav3 vector compositions and methods of use in gene therapy of human liver cancer | |
EP2173740A4 (en) | Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system | |
EP2152304A4 (en) | Nanoemulsion therapeutic compositions and methods of using the same | |
PT2162118T (en) | Porous microspheres and their use in therapy | |
EP2170950A4 (en) | Anti-il-20 antibody and its use in treating il-20 associated inflammatory diseases | |
EP2173337A4 (en) | Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin | |
HK1204626A1 (en) | Use of cd83 in combination therapies cd83 | |
EP2271325A4 (en) | Methods and use of inducing apoptosis in cancer cells | |
EP2049121A4 (en) | Methods and compositions for promoting activity of anti-cancer therapies | |
EP2213309A4 (en) | Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent | |
IL195817A0 (en) | Use of 2-benzoyl-imidazopyridines in therapeutics | |
GB2431946B (en) | Injectors for use in wellbores and methods of their use | |
IL193663A0 (en) | Thiadiazole compounds and their use in phototherapy | |
GB2434547B (en) | Improvements in and relating to peripheral neurostimulation | |
GB0720445D0 (en) | Anti - cancer activity of GDF-9a and GDF-9b bmp-15 and their use in cancer therapies | |
GB0620675D0 (en) | Anti-cancer activity of GDF-9a and GDF-9b (BMP-15) and their use in cancer therapies | |
ZA200805530B (en) | Morpholino pyrimidine derivatives and their use in therapy | |
GB2438023B (en) | Improvements In And Relating To Construction | |
GB0818663D0 (en) | Gene regulation and its use in therapy | |
GB201006671D0 (en) | Improvements in and relating to construction | |
EP2345717A4 (en) | Cinerarium-derived chromosomal dna involved in synthesis of flavonoid, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |